YP-009

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameYP-009
Drug Alias Namecyclopentenone prostaglandin mimetic (Rosanto)cyclopentenone prostaglandin mimetic (York Pharma)YP-009RPL-208
ClassificationSmall molecules
Mechanisms of ActionTumor necrosis factor α inhibitorsProstanoid receptor agonistsNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complexProstanoid receptorTumor necrosis factor α
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRosanto Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRosanto Pharmaceuticals LtdYork Pharma plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A